170 related articles for article (PubMed ID: 22391791)
1. Pharmacokinetics, lymph node uptake, and mechanistic PK model of near-infrared dye-labeled bevacizumab after IV and SC administration in mice.
Wu F; Tamhane M; Morris ME
AAPS J; 2012 Jun; 14(2):252-61. PubMed ID: 22391791
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence imaging of the lymph node uptake of proteins in mice after subcutaneous injection: molecular weight dependence.
Wu F; Bhansali SG; Law WC; Bergey EJ; Prasad PN; Morris ME
Pharm Res; 2012 Jul; 29(7):1843-53. PubMed ID: 22373666
[TBL] [Abstract][Full Text] [Related]
3. Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance.
Cilliers C; Nessler I; Christodolu N; Thurber GM
Mol Pharm; 2017 May; 14(5):1623-1633. PubMed ID: 28294622
[TBL] [Abstract][Full Text] [Related]
4. Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node.
Heuveling DA; Visser GW; de Groot M; de Boer JF; Baclayon M; Roos WH; Wuite GJ; Leemans CR; de Bree R; van Dongen GA
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1161-8. PubMed ID: 22349719
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive real-time fluorescence imaging of the lymphatic uptake of BSA-IRDye 680 conjugate administered subcutaneously in mice.
Wu F; Bhansali SG; Tamhane M; Kumar R; Vathy LA; Ding H; Yong KT; Bergey EJ; Prasad PN; Morris ME
J Pharm Sci; 2012 May; 101(5):1744-54. PubMed ID: 22262501
[TBL] [Abstract][Full Text] [Related]
6. The lymphatic system plays a major role in the intravenous and subcutaneous pharmacokinetics of trastuzumab in rats.
Dahlberg AM; Kaminskas LM; Smith A; Nicolazzo JA; Porter CJ; Bulitta JB; McIntosh MP
Mol Pharm; 2014 Feb; 11(2):496-504. PubMed ID: 24350780
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program.
Yapa SW; Roth D; Gordon D; Struemper H
Lupus; 2016 Nov; 25(13):1448-1455. PubMed ID: 27072354
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model.
Varkhede N; Forrest ML
J Pharm Pharm Sci; 2018; 21(1s):130s-148s. PubMed ID: 30011390
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus monkeys after iv and sc administration.
Agersø H; Overgaard RV; Petersen MB; Hansen L; Hermit MB; Sørensen MH; Petersen LC; Hilden I
Eur J Pharm Sci; 2014 Jun; 56():65-9. PubMed ID: 24568891
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic modeling of LY2189102 after multiple intravenous and subcutaneous administrations.
Bihorel S; Fiedler-Kelly J; Ludwig E; Sloan-Lancaster J; Raddad E
AAPS J; 2014 Sep; 16(5):1009-17. PubMed ID: 24912797
[TBL] [Abstract][Full Text] [Related]
11. Near infrared fluorescent optical imaging for nodal staging.
Sampath L; Wang W; Sevick-Muraca EM
J Biomed Opt; 2008; 13(4):041312. PubMed ID: 19021320
[TBL] [Abstract][Full Text] [Related]
12. The absorption of darbepoetin alfa occurs predominantly via the lymphatics following subcutaneous administration to sheep.
McLennan DN; Porter CJ; Edwards GA; Heatherington AC; Martin SW; Charman SA
Pharm Res; 2006 Sep; 23(9):2060-6. PubMed ID: 16951999
[TBL] [Abstract][Full Text] [Related]
13. Optical molecular imaging of lymph nodes using a targeted vascular contrast agent.
Licha K; Debus N; Emig-Vollmer S; Hofmann B; Hasbach M; Stibenz D; Sydow S; Schirner M; Ebert B; Petzelt D; Bührer C; Semmler W; Tauber R
J Biomed Opt; 2005; 10(4):41205. PubMed ID: 16178629
[TBL] [Abstract][Full Text] [Related]
14. Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats.
Marshall MV; Draney D; Sevick-Muraca EM; Olive DM
Mol Imaging Biol; 2010 Dec; 12(6):583-94. PubMed ID: 20376568
[TBL] [Abstract][Full Text] [Related]
15. Pan and sentinel lymph node visualization using a near-infrared fluorescent probe.
Josephson L; Mahmood U; Wunderbaldinger P; Tang Y; Weissleder R
Mol Imaging; 2003 Jan; 2(1):18-23. PubMed ID: 12926234
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node mapping by a near-infrared fluorescent heptamethine dye.
Zhang C; Wang S; Xiao J; Tan X; Zhu Y; Su Y; Cheng T; Shi C
Biomaterials; 2010 Mar; 31(7):1911-7. PubMed ID: 19963270
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal concentrations of a near-infrared fluorescence-labeled biotherapeutic determined in situ using confocal scanning laser ophthalmoscopy.
Basile AS; Glazier G; Lee A; Jiang LY; Johnson TR; Shields MJ; Vezina M; Doppalapudi VR
Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6949-58. PubMed ID: 21791590
[TBL] [Abstract][Full Text] [Related]
18. PEGylation does not significantly change the initial intravenous or subcutaneous pharmacokinetics or lymphatic exposure of trastuzumab in rats but increases plasma clearance after subcutaneous administration.
Chan LJ; Bulitta JB; Ascher DB; Haynes JM; McLeod VM; Porter CJ; Williams CC; Kaminskas LM
Mol Pharm; 2015 Mar; 12(3):794-809. PubMed ID: 25644368
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypertonic buffer composition on lymph node uptake and bioavailability of rituximab, after subcutaneous administration.
Fathallah AM; Turner MR; Mager DE; Balu-Iyer SV
Biopharm Drug Dispos; 2015 Mar; 36(2):115-25. PubMed ID: 25377184
[TBL] [Abstract][Full Text] [Related]
20. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
